Skip to main content
Clinical Trials/NCT04897464
NCT04897464
Unknown
Not Applicable

Validation Study of a New Digital Treatment Test Based on Interactive Video Games for Alzheimer's Disease

Braingaze1 site in 1 country60 target enrollmentJune 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer Disease
Sponsor
Braingaze
Enrollment
60
Locations
1
Primary Endpoint
MoCA
Last Updated
4 years ago

Overview

Brief Summary

Oculomotor behavior and cognitive processing of visual information are intimately connected. AD patients show ocular movement problems. Oculomotor deficits are broad consisting mainly of different saccade metrics, altered pupil responses. and smaller and irregular eye vergence movements. Here we test an interactive eye-tracking game to improve eye motion control and thereby training cognitive behavior

Registry
clinicaltrials.gov
Start Date
June 1, 2021
End Date
May 31, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Braingaze
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of MCI or AD

Exclusion Criteria

  • Severe cognitive deterioration
  • History of neurological disease with clinically relevant impact on cognition
  • Severe psychiatric disorder
  • Incidental structural brain findings with impact on cognitive impairment
  • Presence of relevant visual problems

Outcomes

Primary Outcomes

MoCA

Time Frame: immediately after the intervention

Measure changes in MoCA

MMSE

Time Frame: immediately after the intervention

Measure changes in MMSE

Secondary Outcomes

  • CANTAB(immediately after the intervention)

Study Sites (1)

Loading locations...

Similar Trials